Інформація призначена тільки для фахівців сфери охорони здоров'я, осіб,
які мають вищу або середню спеціальну медичну освіту.


Підтвердіть, що Ви є фахівцем у сфері охорони здоров'я.

"Hypertension" №3-4 (65-66), 2019

Back to issue

Association between obstructive sleep apnea and pulmonary hypertension (literature review)

Authors: Крушинська Н.А.(1), Сіренко Ю.М.(2)
(1) — Національний медичний університет імені О.О. Богомольця, м. Київ, Україна
(2) — ДУ «ННЦ «Інститут кардіології імені акад. М.Д. Стражеска» НАМН України, м. Київ, Україна

Categories: Cardiology

Sections: Specialist manual

print version


Summary

У реальній клінічній практиці найчастіше зустрічається легенева гіпертензія (ЛГ) внаслідок хронічних захворювань дихальної системи та/або гіпоксії, яку визначають як ЛГ ІІІ групи за класифікацією Всесвітньої організації охорони здоров’я. Однією з найчастіших причин такої ЛГ є синдром обструктивного апное сну. Метою даного огляду є аналіз літературних даних щодо зв’язку синдрому обструктивного апное сну та ЛГ: клінічна значущість, патогенетичні механізми, обґрунтування необхідності ранньої діагностики та підходи до ведення таких пацієнтів.

В реальной клинической практике наиболее часто встречается легочная гипертензия (ЛГ) вследствие хронических заболеваний дыхательной системы и/или гипоксии, которую обозначают как ЛГ ІІІ группы по классификации Всемирной организации здравоохранения. Одной из самых частых причин такой ЛГ является синдром обструктивного апноэ сна. Целью данного обзора является анализ литературных данных о связи синдрома обструктивного апноэ сна и ЛГ: клиническая значимость, патогенетические механизмы, обоснование необходимости ранней диагностики и подходы к ведению таких пациентов.

Pulmonary hypertension secondary to chronic respiratory diseases and/or hypoxia is the most frequent in real clinical practice. It is classified as World Health Organization group III pulmonary hypertension. One of the most frequent causes of pulmonary hypertension is obstructive sleep apnea. The purpose of this review is to analyze the literature on the correlation between obstructive sleep apnea syndrome and pulmonary hypertension: clinical significance, pathogenesis, proving the necessity of early diagnosis and summarizing approaches to the management of these patients.


Keywords

легенева гіпертензія; синдром обструктивного апное сну; СРАР-терапія; огляд

легочная гипертензия; синдром обструктивного апноэ сна; СРАР-терапия; обзор

pulmonary hypertension; obstructive sleep apnea; continuous positive airway pressure therapy; review


For the full article you need to subscribe to the magazine.


Bibliography

1. Наказ МОЗ України № 384 від 24.05.2012 «Про затвердження та впровадження медико–технологічних документів зі стандартизації медичної допомоги при артеріальній гіпертензії» [Електронний ресурс]. 2012. Режим доступу до ресурсу: https://www.moz.gov.ua/portal/dn_20120524_384.html.

2. Ahmed Q., Chung–Park M., Tomashefski J.F. Cardiopulmonary pathology in patients with sleep apnea/obesity hypoventilation syndrome. Human Pathology. 1997. 28(3). P. 264–269.

3. Alchanatis M., Tourkohoriti G., Kakouros S. et al. Daytime pulmonary hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics Respiration. 2001. 68. P. 566–572.

4. Arias M.A., García–Río F., Alonso–Fernández A. et al. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure. European Heart Journal. 2006. 27. P. 1106–1113.

5. Arzt M., Luigart R., Schum C. et al. Sleep–disordered breathing in deep vein thrombosis and acute pulmonary embolism. Eur. Respir. J. 2012. 40. P. 919–24.

6. Bady E., Achkar A., Pascal S. et al. Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease. Am. J. Respir. Crit. Care Med. 1999. 159. P. 1518–1526.

7. Bady E., Achkar A., Pascal S. et al. Pulmonary arterial hypertension in patients with sleep apnoea syndrome. Thorax. 2000. 55. P. 934–939.

8. Baessler A., Nadeem R., Harvey M. et al. Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers — a meta–analysis. J. Inflamm.(Lond). 2013. 10:13. http://www.journal–inflammation.com/content/10/1/13. doi:10.1186/1476–9255–10–13

9. Bartsch P., Maggiorini M., Ritter M. et al. Prevention of high–altitude pulmonary edema by nifedipine. N. Engl. J. Med. 1991. 325. P. 1284–1289.

10. Berman E.J., DiBenedetto R.J., Causey D.E. et al. Right ventricular hypertrophy detected by echocardiography in patients with newly diagnosed obstructive sleep apnea. Chest. 1991. 100(2). P. 347–350.

11. Bitter T., Faber L., Hering D. et al. Sleep–disordered breathing in heart failure with normal left ventricular ejection fraction. Eur. J. Heart Fail. 2009. 11. P. 602–608.

12. Bonderman D., Jakowitsch J., Adlbrecht C. et al. Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb. Haemost. 2005. 93. P. 512–516.

13. Brown L.M., Chen H., Halpern S. et al. Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL. Registry Chest. 2011. 140. P. 19–26.

14. Chami H.A., Devereux R.B., Gottdiener J.S. et al. Left ventricular morphology and systolic function in sleep–disordered breathing: the Sleep Heart Health study Circulation. 2008. 117. P. 2599–2607.

15. Deandre E. Degey S. Opsomer N. et al. Obstructive sleep apnea and smoking as a risk factor for venous thromboembolism events: review of the literature on the common pathophysiological mechanisms. Obes. Surg. 2016. 26. P. 640–648.

16. Friedman O., Bradley T.D., Chan C.T., Parkes R., Logan A.G. Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug–resistant hypertension. Hypertension. 2010. 56. Р. 1077–1082.

17. Fuhrman C., Fleury B., Nguyên X.L., Delmas M.C. Symptoms of sleep apnea syndrome: high prevalence and underdiagnosis in the French population. Sleep Med. 2012. Vol. 13. 7. P. 852–858.

18. Galiè N., Hoeper M.M., Humbert M. et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur. Heart J. 2009. 30. P. 2493–2537.

19. Galiè N., Humbert M., Vachiery J.L. et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Respir. J. 2015. 46. P. 903–975.

20. Gottlieb D.J., Yenokyan G., Newman A.B. et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the Sleep Heart Health study. Circulation. 2010. 122. P. 352–360.

21. Guilleminault C., Motta J., Mihm F., Melvin K. Obstructive sleep apnea and cardiac index. Chest. 1986. 89(3). P. 331–334.

22. Hedner J., Ejnell H., Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J. Hypertens. 1990. 8. P. 941–946.

23. Heinzer R., Vat S., Marques–Vidal P. et al. Prevalence of sleep–disordered breathing in the general population: the HypnoLaus study. Lancet Respir. Med. 2015. Published Online February 12, 2015. http://dx.doi.org/10.1016/ S2213–2600(15)00043–0.

24. Hetzel M., Kochs M., Marx N. et al. Pulmonary hemodynamics in obstructive sleep apnea: frequency and causes of pulmonary hypertension. Lung. 2003. 181. P. 157–166.

25. Hoeper M.M., Bogaard H.J., Condliffe R. et al. Definitions and diagnosis of pulmonary hypertension. J. Am. Coll. Cardiol. 2013. 62(Suppl.). Р. 42–50.

26. Imran T.F., Ghazipura M., Liu S. et al. Effect of continuous positive airway pressure treatment on pulmonary artery pressure in patients with isolated obstructive sleep apnea: a meta–analysis. Heart Failure Rewiews September. 2016. 21(5). P. 591–598.

27. Ip M.S., Lam B., Chan L.Y. et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am. J. Respir. Crit. Care Med. 2000. 162. P. 2166–2171.

28. Jilwan F.N., Escourrou P., Garcia G. et al. High occurrence of hypoxemic sleep respiratory disorders in precapillary pulmonary hypertension and mechanisms. Chest. 2013. 143. P. 47–55.

29. Kauppert C.A., Dvorak I., Kollert F. et al. Pulmonary hypertension in obesity–hypoventilation syndrome. Respir. Med. 2013. 107. P. 2061–2070.

30. Klinger J.R., Elliott C.G., Levine D.J. et al. Therapy for pulmonary arterial hypertension in adults. Update of the CHEST Guideline and Expert Panel Report. CHEST. 2019. 155(3). P. 565–586.

31. Kohler M., Stradling J.R. Mechanisms of vascular damage in obstructive sleep apnea. Nat. Rev. Cardiol. 2010. 7. P. 677–685.

32. Lam C.S., Roger V.L., Rodeheffer R.J. et al. Pulmonary hypertension in heart failure with preserved ejection fraction: a community–based study. J. Am. Coll. Cardiol. 2009. 53. P. 1119–1126.

33. Launay J.M., Herve P., Peoch K. et al. Function of the serotonin 5–hydroxytryptamine 2B receptor in pulmonary hypertension. Nat. Med. 2002. 8. P. 1129–1135.

34. Li J.M., Shah A.M. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004. 287. Р. 1014–1030.

35. Liak C., Fitzpatrick M. Coagulability in obstructive sleep apnea. Can. Respir. J. 2011. 18. P. 338–48.

36. Marvisi M., Vento M.G., Balzarini L. et al. Continuous positive airways pressure and uvulopalatopharyngoplasty improves pulmonary hypertension in patients with obstructive sleep apnoea. Lung. 2015. 193(2). P. 269–274.

37. McLaughlin V.V., Archer S.L., Badesch D.B. et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J. Am. Coll. Cardiol. 2009. 53. P. 1573–1619.

38. McNicholas W.T., Bonsignore M.R. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. European Respiratory Journal. 2007. 29(1). P. 156–178.

39. Mereles D., Ehlken N., Kreuscher S. et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006. 114. P. 1482–1489.

40. Minai O.A., Ricaurte B., Kaw R. et al. Frequency and impact of pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am. J. Cardiol. 2009. 104. P. 1300–1306.

41. Minic M., Granton J.T., Ryan C.M. Sleep disordered breathing in group 1 pulmonary arterial hypertension. J. Clin. Sleep Med. 2014. 10. P. 277–283.

42. Nahmias J., Lao R., Karetzky M. Right ventricular dysfunction in obstructive sleep apnoea: reversal with nasal continuous positive airway pressure. Eur. Respir. J. 1996. 9. P. 945–951.

43. Phillips B.G., Narkiewicz K., Pesek C.A. et al. Effects of obstructive sleep apnea on endothelin–1 and blood pressure. J.
Hypertens. 1999. 17. P. 61–66.

44. Raskin J., Qua D., Marks T., Sulica R. A retrospective study on the effects of pulmonary rehabilitation in patients with pulmonary hypertension. Chronic Respir. Dis. 2014. 11. P. 153–162.

45. Ryan S., Taylor C.T., McNicholas W.T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation. 2005. 112. P. 2660–2667.

46. Sajkov D., Wang T., Saunders N.A. et al. Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung
disease. Am. J. Respir. Crit. Care Med. 1999. 159. P. 1518–1526.

47. Sajkov D., Wang T., Saunders N.A. et al. Continuous po–sitive airway pressure treatment improves pulmonary hemodyna–mics in patients with obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 2002. 165. P. 152–158.

48. Singh M., Liao P., Kobah S. et al. Proportion of surgical patients with undiagnosed obstructive sleep apnoea. Br. J.
Anaesth. 2013. 110(4). P. 629–636.

49. Smith M.L., Niedermaier O.N.W., Hardy S.M. et al. Role of hypoxemia in sleep apnea–induced sympathoexcitation. Journal of the Autonomic Nervous System. 1996. 56(3). P. 184–190.

50. Somers V.K., Dyken M.E., Skinner J.L. Autonomic and hemodynamic responses and interactions during the Mueller maneuver in humans. Journal of the Autonomic Nervous System. 1993. 44(2–3). P. 253–259.

51. Somers V.K., Mark A.L., Zavala D.C., Abboud F.M. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. Journal of Applied Physiology. 1989. 67(5). P. 2101–2106.

52. Szulcek R., Happe C.M., Rol N. et al. Delayed microvascular shear adaptation in pulmonary arterial hypertension. Role of platelet endothelial cell adhesion molecule–1 cleavage. Am. J. Respir. Crit. Care Med. 2016. 193. P. 1410–1420.

53. Tilkian A.G., Guilleminault C., Schroeder J.S. Hemodynamics in sleep induced apnea. Studies during wakefulness and sleep. Annals of Internal Medicine. 1976. 85(6). P. 714–719.

54. Ulrich S., Keusch S., Hildenbrand F.F. et al. Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with pre–capillary pulmonary hypertension and sleep–disturbed breathing: randomized, double–blind, cross–over trial. Eur. Heart J. 2015. 36. P. 615–623.

55. Virolainen J., Ventila M., Turto H., Kupari M. Effect of negative intrathoracic pressure on left ventricular pressure dyna–mics and relaxation. Journal of Applied Physiology. 1995. 79(2). P. 455–460.

56. Wang B., Yan B., Song D., Ye X., Liu SF. Chronic intermittent hypoxia down–regulates endothelial nitric oxide synthase expression by an NF–κB–dependent mechanism. Sleep Med. 2012. 14. P. 165–171.

57. Wang Z., Li AY., Guo Q.H. et al. Effects of cyclic intermittent hypoxia on ET–1 responsiveness and endothelial dysfunction of pulmonary arteries in rats. PLoS One. 2013. 8. e. 58078.

58. White L.H., Bradley T.D. Role of nocturnal rostral uid shift in the pathogenesis of obstructive and central sleep apnoea. J. Physiol. 2013. 591. P. 1179–93.

59. Xue Yu, Zhiwei Huang, Yi Zhang et al. Obstructive sleep apnea in patients with chronic thromboembolic pulmonary hypertension. J. Thorac. Dis. 2018. 10(10). P. 5804–5812.

Similar articles

Можливості діагностики синдрому обструктивного апное сну за допомогою портативних моніторів
Authors: Сіренко Ю.М., Крушинська Н.А., Сидоренко П.І., Поліщук С.А. — ДУ «ННЦ «Інститут кардіології ім. акад. М.Д. Стражеска» НАМН України; Погорецький Ю.Н. — Лабораторія сну «УкрТелеМед», м. Київ
"Hypertension" 1 (39) 2015
Date: 2015.05.28
Categories: Cardiology
Sections: Clinical researches
Dynamics of Conditions of Arterial Stiffness in Hypertensive Patients with Obstructive Sleep Apnea
Authors: Krushynska N.A., Sirenko Yu.M.
SI «NSC «The Institute of Cardiology named after academician M.D. Strazhesko» of NAMS of Ukraine

"Hypertension" 1 (45) 2016
Date: 2016.03.21
Categories: Cardiology
Sections: Clinical researches
Arterial hypertension, obstructive sleep apnea  and cardiovascular risk
Authors: Сіренко Ю.М.(1), Крушинська Н.А.(2), Рековець О.Л.(1)
(1) — ДУ «ННЦ «Інститут кардіології імені акад. М.Д. Стражеска» НАМН України», м. Київ, Україна
(2) — Національний медичний університет імені О.О. Богомольця, м. Київ, Україна

"Hypertension" №1 (57), 2018
Date: 2018.03.28
Categories: Cardiology
Sections: Clinical researches
Authors: Візір В.А., Садомов А.С., Запорізький державний медичний університет
"Hypertension" 6 (8) 2009
Date: 2010.06.23
Categories: Family medicine/Therapy, Cardiology, Therapy

Back to issue